# Toregem Biopharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/toregem-biopharma

- Industry: Pharmaceuticals
- Headquarters: Japan
- Website: www.toregem.co.jp
- Total disclosed funding: $13M
- Latest round: Series B (Aug 30, 2024)
- Investors on record: 6

## About

Founded in 2020 and based in Kyoto, Japan, Toregem Biopharma operates as a researcher and developer of antibiotic drugs that help with tooth regeneration. In May 2026, Toregem Biopharma raised JPY 850 million in pre-series C funding from OSAKA University Venture Capital, SIIF Impact Capital, Chushin Venture Capital, Bi Holdings Co., Ltd. and SHOFU INC. and JIC Venture Growth Investments. As of May 2026, the company is being led by its representative director, Honoka Kiso.

The firm develops and offers treatment for patients with congenital tooth loss and other dental anomalies, ultimately providing solutions for those with tooth defects. The company seeks to deliver therapies that promote tooth growth from patients' own tissues, thereby enhancing quality of life through improved dental health.

The company plans to use May 2026 funding to advance clinical development of its drug candidate, including Phase 2 and overseas trials, while strengthening its organizational capabilities through hiring.

## Funding rounds

- Series B, Aug 30, 2024, $10M — Astellas Venture Management, Mitsubishi UFJ Capital, TOHOKU University Venture Partners, Kyoto University Innovation Capital, Kyoto Capital Partners, JIC Venture Growth Investments
- Series B, Jul 3, 2023, $2.6M — JIC Venture Growth Investments
- Series A, May 6, 2021, $0.1M — Kyoto Capital Partners
- Series A, Sep 3, 2020, $0.5M — Kyoto University Innovation Capital

## Investors

- Kyoto University Innovation Capital (https://capitalatlas.ai/funds/kyoto-university-innovation-capital) — Series A, Series B
- Kyoto Capital Partners (https://capitalatlas.ai/funds/kyoto-capital-partners) — Series A, Series B
- JIC Venture Growth Investments (https://capitalatlas.ai/funds/jic-venture-growth-investments) — Series B
- Astellas Venture Management (https://capitalatlas.ai/funds/astellas-venture-management) — Series B
- Mitsubishi UFJ Capital (https://capitalatlas.ai/funds/mitsubishi-ufj-capital) — Series B
- TOHOKU University Venture Partners (https://capitalatlas.ai/funds/tohoku-university-venture-partners) — Series B